Worth reading
40Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
169000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock options (new share acquisition rights)
発行・処分する株式数
100 shares per right; total shares underlying the grant: 169,000 shares (1,690 stock acquisition rights)
Intended allottee
Name The Company's directors (excluding directors who are Audit & Supervisory Committee Members) / Number of Employees 1 / Number of stock acquisition rights 500 rights, Name Executive officers and employees of the Company / Number of Employees 32 / Number of stock acquisition rights 1,190 rights
Nil per stock acquisition right
Total issue value
No consideration
Terms of the stock acquisition rights
Exercise price
The closing price of the Company’s common stock on the Tokyo Stock Exchange on the date of allotment. The terms provide for adjustments in the event of a share split or consolidation, or the issuance of new shares at a price below market value, among other events. The floor is Not disclosed.
Exercise period
Start Date 9 April 2029 / End date 8 April 2035
Number of Stock Acquisition Rights
Total number issued 1,690 stock acquisition rights (planned number to be allotted) / Number of unexercised units Not disclosed
Reason for acquisition without consideration
If the rights can no longer be exercised before exercise due to the exercise conditions or the stock acquisition rights allotment agreement. If a proposal for a merger, company split, share exchange, share transfer, conversion into a company with transfer restrictions or other similar transaction is approved.
Categories and Number of Persons Covered
Category Directors (excluding directors who are Audit and Supervisory Committee members) / Number of Employees 1 / Number of allocated stock acquisition rights 500 rights, Category Executive officers and employees / Number of Employees 32 / Number of allocated stock acquisition rights 1,190 rights
Basis for determining the amount to be paid
The exercise price will be the closing price of the Company’s common stock on the Tokyo Stock Exchange on the date of allotment of the stock acquisition rights, or, if there is no closing price on that date, the closing price on the most recent preceding trading day. The discount rate and premium rate are Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock options (new share acquisition rights) |
| Number of shares to be issued or disposed of | 100 shares per right; total shares underlying the grant: 169,000 shares (1,690 stock acquisition rights) |
| Issue price and disposal price | Nil per stock acquisition right |
| Total issue value | No consideration |
| Intended allottee | Name The Company's directors (excluding directors who are Audit & Supervisory Committee Members) / Number of Employees 1 / Number of stock acquisition rights 500 rights, Name Executive officers and employees of the Company / Number of Employees 32 / Number of stock acquisition rights 1,190 rights |
| Basis for determining the amount to be paid | The exercise price will be the closing price of the Company’s common stock on the Tokyo Stock Exchange on the date of allotment of the stock acquisition rights, or, if there is no closing price on that date, the closing price on the most recent preceding trading day. The discount rate and premium rate are Not disclosed. |
| Exercise price | The closing price of the Company’s common stock on the Tokyo Stock Exchange on the date of allotment. The terms provide for adjustments in the event of a share split or consolidation, or the issuance of new shares at a price below market value, among other events. The floor is Not disclosed. |
| Exercise period | Start Date 9 April 2029 / End date 8 April 2035 |
| Number of Stock Acquisition Rights | Total number issued 1,690 stock acquisition rights (planned number to be allotted) / Number of unexercised units Not disclosed |
| Reason for acquisition without consideration | If the rights can no longer be exercised before exercise due to the exercise conditions or the stock acquisition rights allotment agreement. If a proposal for a merger, company split, share exchange, share transfer, conversion into a company with transfer restrictions or other similar transaction is approved. |
| Categories and Number of Persons Covered | Category Directors (excluding directors who are Audit and Supervisory Committee members) / Number of Employees 1 / Number of allocated stock acquisition rights 500 rights, Category Executive officers and employees / Number of Employees 32 / Number of allocated stock acquisition rights 1,190 rights |
Items this document does not state (17)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To increase the recipients’ motivation and morale to contribute to improving the Company’s medium- to long-term performance and corporate value, and to ensure that they share with shareholders not only the benefits of a rising share price but also the risks associated with share-price fluctuations.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.